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Bioimpedance norms for the hemodialysis population. More than 3,000
hemodialysis patients were examined with single-frequency bioelectrical
impedance analysis (BIA). Distributions of resistance, reactance, phase
angle (PA), and estimates of total body water (TBW) and body cell mass
(BCM) by BIA were determined, and compared with traditional labora-
tory markers of nutritional status. Bioimpedance parameters and body
composition estimates differed significantly by age, sex, race, and diabetic
status. PA and BCM correlated directly with serum creatinine, albumin,
and prealbumin concentrations. Population-based norms for bioimped-
ance parameters and estimates of body composition are provided.
Protein energy malnutrition afflicts a large fraction of hemodi-
alysis patients [1—3] and is an important determinant of mortality
and morbidity [4—8]. Several methods of nutritional assessment
have been applied in this population, including estimates of
dietary intake, anthropometry, and biochemical tests consisting of
serum concentrations of creatinine, albumin, and prealbumin.
These biochemical indicators have been repeatedly shown to
predict survival in hemodialysis patients, although their levels can
be confounded by other disease processes (such as liver disease),
and they do not capture the entire realm of malnutrition. Body
composition analysis has attracted some interest, however, most
diagnostic methods are too costly and/or cumbersome to be
applied in clinical practice.
Bioelectrical impedance analysis (BIA) has been explored as a
method of body composition analysis for more than a decade [9]
and has recently been applied to the dialysis population by several
groups of investigators [10—14]. BIA is based on the bioelectrical
principle of impedance (Z), the vector sum of resistance and
reactance. Resistance (R) is the opposition to electrical current
related to the length and diameter of a cylinder. The human body
resembles a set of serially connected cylinders (such as arms, legs,
and trunk) with known height and relatively constant diameter. If
length and diameter are known, R reflects the volume of the
cylinder's fluid contents, which carry an electrical charge. Reac-
tance (Xc) reflects the portion of impedance due to the presence
of capacitive elements, such as cell membranes. Derivations of
these quantities have been used to estimate body composition,
having been validated in healthy populations. We validated BIA
as a body composition tool in hemodialysis patients, comparing
total body water (TBW) and body cell mass (BCM) to deuterium
oxide dilution, and a combination of dual-energy x-ray absorpti-
ometry and sodium bromide dilution, respectively [15]. The
principle objectives of the current study were to: (1) determine
population-based norms for bioimpedance parameters (R, Xc,
and phase angle) and estimates of body composition (TBW and
BCM, with or without adjustment for body wt); (2) examine the
associations among these parameters and selected demographic
factors (age, sex, race, and diabetic status); and (3) explore
relations among these parameters and traditional laboratory
surrogates of nutritional status,
METHODS
Study subjects
Study participants (N = 3009) were thrice weekly hemodialysis
patients for three or more months at 101 free-standing Fresenius
Medical Care - N. A. dialysis units geographically distributed
across the United States. Persons aged below 18 years or with an
amputation above the transmetatarsal site were excluded from
participation. The height, weight, reactance (Xc), and resistance
(R) were recorded. Quetelet's index (weight in kg divided by
height in meters squared) and phase angle (PA, the arc tangent of
the reactance to resistance ratio, multiplied by 180/Il to convert
radians to degrees) were calculated. Total body water (TBW) and
body cell mass (BCM) were estimated based on raw anthropo-
metric and bioimpedance parameters using proprietary software
(Fluid and Nutrition, Version 3.0). Total body water and BCM as
a percent of body wt were calculated. These data were merged
with demographic and laboratory data (mean over 3 months
preceding survey) from the Patient Statistical Profile, a database
with selected demographic, historic, and laboratory information
on patients cared for at Fresenius Medical Care - N. A. dialysis
facilities.
Bioelectrical impedance analysis
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Bioelectrical impedance analysis was performed before a mid-
week dialysis session (Wednesday or Thursday) during the first
half of 1995. Briefly, an inner electrode was attached to the dorsal
surface of the wrist on the arm without an arteriovenous fistula or
graft. An outer electrode was placed on the dorsal surface of the
third metacarpal bone. A second pair of electrodes was positioned
on the anterior surface of the ipsilateral ankle and the dorsal
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surface of the third metatarsal bone [91. A single frequency
low-amplitude imperceptible current (800 mA at 50 kHz) was
introduced via the electrodes on the hand and foot. The voltage
drop was detected by the electrodes at the wrist and ankle. The
procedure was performed in five minutes or less. The bioelectrical
impedance analyzer used in this study (BIA Quantum, RJL
Systems, Clinton Twp., MI, USA) vectored the impedance signal
(Z, in ohms,() into resistance (R, Il) and reactance (Xc, ci) as a
direct series measurement. Resistance and reactance were re-
corded and the phase angle (are tangent of the Xc/R ratio) was
calculated. Resistance is relatively low in lean tissue that contains
large amounts of water and electrolytes, and relatively high in
adipose tissue and bone. Reactance is the opposition to flow of
electric current due to capacitance, represented in vivo by cell
membranes. Phase angle can range in theory from 0 to 90 degrees;
0 degrees if the circuit is only resistive (a system with no cell
membranes) and 90 degrees if the circuit is only capacitive (a
system of membranes with no fluid). For body composition
estimates, R and Xc were mathematically transformed to their
equivalent parallel values and adjusted for stature by the use of
exponential relationships to compensate for the irregular geom-
etries of the human body [161.
Statistical analysis
Continuous variables, expressed as mean SD, were compared
with analysis of variance. The method of least squares regression
was used to determine mean bioimpedance and body composition
values, simultaneously adjusting for age, sex, race, and diabetes.
Seheffe's test was used for pairwise comparisons across categories
of age. Correlations were described with the Pearson product
moment coefficient. Two-tailed P-values less than 0.05 were
considered significant. Statistical analyses were conducted using
SAS 6.08 (The SAS Institute, Cary, NC, USA).
RESULTS
There were 3009 study participants who had a mean age of
60.5 15.5 years. Dialysis duration was 3.8 3.7 years (median
2.6 years, range < 1 to 27.3years). Forty-seven point two percent
of subjects were female. The distribution of race or ethnicity was
African-American 46.9%, Caucasian 45.4%, Hispanic 6.5%, and
other 1.2%. Mean serum albumin was 3.85 0.36 g per dl,
creatinine 10.8 3.5 mg per dl, pre-dialysis blood urea nitrogen
67.7 17.2 mg per dl, prealbumin 26.7 6.4 mg per dl,
transferrin 155.3 31.6 mg per dl, and cholesterol 176.2 45.6
mg per dl.
Mean height was 1.67 0.11 m, and mean weight was 74.3
18.5 kg. Quetelet's index was 27.3 1.9 kg per m2. Mean
reactance was 41 14 ci and mean resistance was 498 99 ci,
corresponding to a phase angle of 4.82 1.77 degrees. The
calculated mean TBW was 40.8 9.3 kg (55.8% 8.8% of body
wt), and calculated mean BCM was 26.1 5.8 kg (36.1% 7.6%
of body wt).
Bioimpedance parameters
Resistance (R) tended to increase with increasing age (481, 476,
482, 497, 512, and 523 ci, for ages less than 40, 40 to 49, 50 to 59,
60 to 69, 70 to 79, and 80 or more, P < 0.0001, linear estimate 9.0
ci per 10 year increase, P < 0.0001); patients aged 60 or above had
significantly increased R compared with younger patients. Resis-
tance was significantly higher in women compared with men (531
vs. 460 11, P < 0.0001), and in patients without diabetes compared
with those with diabetes (511 vs. 480 ci, P < 0.0001). There was a
small difference in R by race or ethnicity, of borderline statistical
significance (499 vs. 491 ci, in non-African-American patients
compared with African-Americans, P = 0.02).
Reactance (Xc) tended to decrease with increasing age (46.5,
42.1, 42.4, 39.1, 38.5, and 35.8 ci, for age less than 40, 40 to 49, 50
to 59, 60 to 69, 70 to 79, and 80 or more, P < 0.0001, linear
estimate —1.9 ci per 10 year increase, P < 0.0001); patients aged
60 or above had significantly decreased Xe compared with
younger patients. There was no difference in Xc by sex (40.9 vs.
40.6 ci, for women vs. men, P = 0.48). Reactance was significantly
higher in African-Americans compared with patients of other
races or ethnieities (43.7 vs. 37.7 ci, P < 0.0001), and significantly
lower in patients with diabetes compared with those without
diabetes (38.9 vs. 42.5 ci, P < 0.0001).
Phase angle was decreased (more narrow) with increasing age
(5.62, 5.17, 5.12, 4.60, 4.43, and 3.97 degrees, for age less than 40,
40 to 49, 50 to 59, 60 to 69, 70 to 79, and 80 or more, P < 0.0001,
linear estimate —0.30 degrees per 10 year increase, P < 0.0001);
the phase angle was significantly more narrow in patients aged 60
or above. The phase angle was wider in men compared with
women (5.11 vs. 4.52 degrees, P < 0.0001), in African-Americans
compared with patients of other races or ethnieities (5.20 vs. 4.44
degrees, P < 0.0001), and in patients with diabetes compared with
those without diabetes (4.91 vs. 4.72 degrees, P = 0.003).
Quetelet's index
There was a significant difference in Quetelet's index across
categories of age, in part because of low variability (27.3, 26.9,
27.2, 27.5, 27.6, and 27.8 kg per m2, for ages less than 40, 40 to 49,
50 to 59, 60 to 69, 70 to 79, and 80 or more, P < 0.0001), with a
trend toward an increased Quetelet's index with age (linear
estimate 0.12 kg per m2 per 10 year increase, P < 0.0001). Values
of Quetelet's index were larger in women compared with men
(28.5 vs. 26.3 kg per m2, P < 0.0001), and slightly smaller in
African-Americans compared with patients of other races or
ethnicities (27.3 vs. 27.5 kg per m2, P = 0.0006). There was no
difference in Quetelet's index by diabetic status (27.4 vs. 27.4 kg
per m2, P = 0.66).
Total body water
Total body water (TBW) varied significantly with age (41.5,
43.4, 42.7, 40.4, 39.1, and 37.5 kg for ages less than 40, 40 to 49, 50
to 59, 60 to 69, 70 to 79, and 80 or more, P < 0.0001, linear
estimate —0.92 kg per 10 year increase, P < 0.0001); patients aged
60 or above had significantly lower TBW than younger patients.
Total body water as a percentage of body wt (TBW%) also varied
with age, with patients at both extremes exhibiting the highesi
proportional body water weight (56.7%, 55.2%, 53.7%, 55.1%.
55.7%, and 56.9% in corresponding categories, P < 0.0001).
suggesting a significant loss of fat mass in elderly patients. Total
body water was significantly larger in men compared with women
(46.5 vs. 35.0 kg, P < 0.0001), in African-Americans compared
with patients of other races or ethnicities (41.4 vs. 40.2 kg, P <:
0.0001), and in patients with diabetes compared with those
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Table 1. Norms of bioimpedance parameters and derived estimates of body composition
5% 10% 25% 50% 75% 90% 95%
Men (N = 1590)
R 344 369 408 458 513 570 616
Xc 24 26 32 39 48 57 65
PA 2.86 3.44 4.01 5.16 5.73 6.88 8.02
TBW 33.9 36.5 40.4 45.8 51.0 56.9 60.5
TBW% 49% 52% 55% 59% 64% 68% 71%
BCM 22.1 23.6 26.5 29.6 33.1 36.4 38.2
BCM% 28% 31% 35% 39% 43% 47% 50%
Women (N = 1419)
R 380 413 463 528 599 668 718
Xc 22 25 31 38 48 58 67
PA 2.29 2.86 3.44 4.01 5.16 6.30 7.45
TBW 25.9 27.9 30.6 34.1 38.1 42.7 45.3
TBW% 39% 41% 46% 51% 57% 63% 66%
BCM 17.4 18.4 19.9 21.6 23.6 25.7 27.6
BCM% 22% 24% 28% 32% 37% 42% 45%
Abbreviations are in the Appendix.
without diabetes (41.9 vs. 39.7 kg, P < 0.0001). Total body water
as a percentage of body wt (TBW%) was significantly larger in
men compared with women (59.5% vs. 51.6%, P < 0.0001), but
was significantly smaller in patients with diabetes compared with
those without diabetes (54.7% vs. 56.4%, P < 0.0001). There was
no difference in TBW% across race or ethnicity (55.3% vs. 55.8%,
P = 0.13, African-American vs. other).
Body cell mass
Body cell mass (BCM) tended to decrease with increasing age
(27.4, 27.6, 27.0, 25.5, 24.7, and 23.6 kg, for ages less than 40, 40
to 49, 50 to 59, 60 to 69, 70 to 79, and 80 or more, P < 0.000 1,
linear estimate —0.81 kg per 10 year increase, P < 0.0001).
Expressed as a percentage of body wt, BCM% was larger at the
extremes of age, as was TBW% (38.1%, 35.6%, 34.4%, 34.9%,
35.7%, and 36.1% in corresponding categories, P < 0.0001).
Body cell mass was significantly larger in men compared with
women (29.9 vs. 22.1 kg, P < 0.0001) and in African-Americans
compared with patients of other races or ethnicities (26.8 vs.
25.1 kg, P < 0.0001). There was no difference in BCM in
patients with or without diabetes (26.0 vs. 26.0 kg, P = 0.81).
Body cell mass as a percentage of body wt (BCM%) was
significantly larger in men compared with women (38.6% vs.
33.0%, P < 0.0001), and in African-Americans compared with
patients of other races or ethnicities (36.4% vs. 35.3%, P <
0.0001). In patients with diabetes, BCM% was significantly
smaller (34.3% vs. 37.3%, P < 0.0001) than in patients without
diabetes, suggesting that their ratio of extracellular to intracel-
lular water was increased.
Reference table
Table I provides "norms" of bioimpedance parameters and
derived body composition estimates (5%, 10%, 25%, 50%, 75%,
90%, and 95%) for hemodialysis patients stratified by sex.
Correlation with laboratory markers of nutrition
Table 2 outlines the correlation among bioimpedance parame-
ters and laboratory markers of nutrition. Phase angle was the
bioimpedance parameter most closely correlated with laboratory
nutritional surrogates. Phase angle, BCM, and TBW correlated
more closely with serum creatinine than with serum albumin or
prealbumin. Partial correlation coefficients demonstrated that the
correlation between PA and albumin was attenuated when ad-
justed for creatinine (data not shown). Quetelet's (body mass)
index was unrelated to bioimpedance or biochemical nutritional
parameters (r < 0.1 in all cases, P = NS). Correlations among
BIA and laboratory tests tended to be higher in men compared
with women.
DISCUSSION
To our knowledge, this is the largest experience with BIA in
hemodialysis patients to date. Population-based norms for bioim-
pedance parameters were determined, allowing interpretation of
BIA results across institutions. Age-, sex-, race-, and diabetes-
related mean differences in bioimpedance parameters were de-
termined. We established a direct correlation (r range 0.20 to
0.45) among phase angle and BCM and traditional biochemical
nutritional surrogates in hemodialysis, including creatinine, albu-
min, and prealbumin.
Although commercial users of BIA have focused on estimates
of body composition, the calculation of body compartments
requires regression adjustment of raw Xc and R values. Although
the product (such as fat-free mass) is something more easily
interpretable to the lay person than a value in fl or fl m', the
process of regression adjustment introduces unnecessary error
into the calculations. We have previously shown that the coeffi-
cient of variation for BIA is quite low (< 4%) [15].
The correlations among bioimpedance parameters and several
biochemical measures of nutritional status (creatinine, albumin,
prealbumin) were modest. There are two alternative explanations
for these findings: (1) Bioimpedance is not a valid marker of
nutritional status or general health; or (2) Bioimpedance and the
biochemical markers capture somewhat different dimensions of
nutritional status or general health. We strongly suspect the latter
explanation. Other studies in ESRD have clearly shown the
independent predictive power of disparate markers of malnutri-
tion (such as low serum protein levels, "B" or "C" designation on
SGA). Moreover, BIA may be a more sensitive indicator of
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Table 2. Correlation among bioimpedance parameters and laboratory measures of nutritional status
malnutrition than other commonly-used methods. It is noteworthy
that less than 10% of hemodialysis patients have a phase angle
wider than the mean for a normal population (R.J. Liedtke,
personal communication).
It is of keen interest that the most commonly employed
indicator of body composition (Quetelet's index) was uncorre-
lated with bioimpedance or biochemical parameters in this pop-
ulation. Quetelet's index was insensitive to changes in body
composition known to occur with age, such as loss of body cell
mass, or gain in body fat or extracellular water. The inability to
capture the distribution of body wt underscores the weakness of
weight-adjusted-for-height equations as primary predictive tools
for body composition analysis. More importantly, it is possible
that reliance on Quetelet's index or other related indices of body
composition will lead to a marked underestimation of the associ-
ation between altered body composition and adverse clinical
outcomes, which could have important public health conse-
quences beyond the hemodialysis population [17, 181.
In summary, 3009 patients with ESRD on hemodialysis under-
went BIA. Population-based norms for hioimpedance parameters
(R, Xc, phase angle) and derived estimates of body composition
(TBW, BCM) were determined. Age-, sex-, race-, and diabetes-
related differences were highlighted. Applied clinical research will
be required to determine whether BIA can be used to gauge
response to nutrition support or to other clinical interventions in
patients with ESRD.
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APPENDIX
Abbreviations used in this article are: BIA, bioelectrical impedance
analysis; PA, phase angle; TBW, total body water; BCM, body cell mass;
R, resistance; Z, impedance; Xc, reactance; fl ohm; BCM%, body cell
mass as a percentage of body weight; ESRD, end-stage renal disease;
SGA, subjective global assessment; TBW%, total body water as a percent-
age of body weight.
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